MedPath

Safety Study of Viaskin Peanut to Treat Peanut Allergy

Phase 3
Completed
Conditions
Peanut Allergy
Registration Number
NCT02916446
Lead Sponsor
DBV Technologies
Brief Summary

This study evaluates the safety of Viaskin Peanut 250 mcg in the treatment of peanut allergy in children from 4 to 11 years of age. Subjects will receive either Viaskin Peanut 250 mcg or a placebo for a period of 6 months, after which all subjects will be receiving the active treatment up to a period of 3 years under active treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
393
Inclusion Criteria
  • Physician-diagnosed peanut allergy;
  • A peanut Skin Prick Test (SPT) with a wheal largest diameter ≥8 mm;
  • A specific-peanut Immunoglobulin E (IgE) ≥14 kU/L;
  • Subjects following a strict peanut-free diet.
Exclusion Criteria
  • Generalized dermatologic disease
  • Spirometry forced expiratory volume in 1 second (FEV1) <80% of the predicted value, or peak expiratory flow (PEF) <80% of predicted value;
  • Receiving β-blocking agents, angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, calcium channel blockers or tricyclic antidepressant therapy; anti-tumor necrosis factor drugs or anti-IgE drugs (such as omalizumab) or any biologic immunomodulatory therapy;
  • Prior or concomitant history of any immunotherapy to any food allergy (for example EPIT, OIT, SLIT, or specific oral tolerance induction).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Adverse Events (AEs), Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Through study completion, an average of 3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (32)

Arkansas Children's Hospital

🇺🇸

Little Rock, Arkansas, United States

Allergy & Asthma Associates of Southern California

🇺🇸

Mission Viejo, California, United States

Palos Verdes Medical Group

🇺🇸

Rolling Hills Estates, California, United States

Stanford University School of Medicine

🇺🇸

Stanford, California, United States

Children's Hospital Colorado

🇺🇸

Aurora, Colorado, United States

National Jewish Health

🇺🇸

Denver, Colorado, United States

Sarasota Clinical Research

🇺🇸

Sarasota, Florida, United States

Atlanta Allergy & Asthma Clinic

🇺🇸

Marietta, Georgia, United States

Ann & Robert H. Lurie Children's Hospital of CHicago

🇺🇸

Chicago, Illinois, United States

Sneeze, Wheeze and Itch Associates,Clinical Research

🇺🇸

Normal, Illinois, United States

Scroll for more (22 remaining)
Arkansas Children's Hospital
🇺🇸Little Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.